North Texas Leadership Giving Circle

Founding Members

Samantha and Timothy Durst, Debbie and Danny McQuary, Cambria and Brian Reinsborough, Cynthia and Steven Rigby, Mona Carlton Stogner and Grey Stogner

 

Founding Friends

Don Armstrong, Frances and Jim Broussard, Tracy and Ballard Castleman, Janet and H. Craig Evans, Brenda and Mark Gribbin, Meredith and James Hogan, Raanan Horowitz, Maggie Kipp, George Meza, Erin and Kyle Ragsdale, Patricia and Travis Thomson, Debbie and Alvin Wade, Lillie and Charles Young

 

 

Overview

The Leukemia & Lymphoma Society's flagship North Texas Leadership Giving Circle is comprised of community leaders who support our vision of a world without blood cancer.  To achieve this vision, these philanthropists stand together with significant investments to help accelerate cures not only for Texas families, but the one million Americans affected by blood cancers.  More than 46,000 North Texans are impacted by blood cancers, with 11,000 new cases diagnosed just this year.

Membership in the North Texas Leadership Giving Circle involves a three-year gift commitment that will further the advancement of blood cancer research and treatment and in turn, the patients affected by them.  For over 60 years, LLS has invested more than $1 billion in developing better cancer treatments leading to patients living longer, healthier lives.  LLS currently funds over $22 million in cancer research at renowned institutions across the state of Texas.  The priority of the North Texas Leadership Giving Circle is to impact the lives of patients and their families throughout their blood cancer journey and to ultimately put an end to blood cancers.  Through your participation in the North Texas Leadership Giving Circle, members will significantly impact the future of all cancer treatments and the lives of patients and help move us closer to a world without cancer.

 

Membership Benefits

With your three-year commitment and membership to the North Texas Leadership Giving Circle you are providing assistance for newly-diagnosed blood cancer patients, supporting the quality of cancer survival, serving as a catalyst for change and providing critical support for blood cancer research.  Along with this impact, your commitment and membership entitles you to receive exclusive benefits including invitations to the Leadership Giving Circle Reception, Inspiration Brunch and Researcher Vision Reception.  In addition, with gifts at a certain level, you can direct your investment to one of thirteen personalized research portfolios.

Current research portfolios include:

  • Acute Lymphoblastic Leukemia
  • Acute Myelogenous Leukemia/Myelodysplastic Syndromes
  • Chronic Lymphocytic Leukemia
  • Chronic Myelogenous Leukemia
  • Hodgkin's Lymphoma
  • non-Hodgkin's Lymphoma - Indolent
  • non-Hodgkin's Lymphoma - Aggressive
  • Myeloma
  • Pediatric Blood Cancers
  • Quality of Life (long-term, late effects research)
  • Immunotherapies
  • Targeted Therapies
  • Stem Cell Transplants